Last week, the House passed a Pelosi-backed prescription drug bill that would allow Medicare to negotiate with pharmaceutical companies for lower prices.
If signed into law, H.R.3 would also establish a $2,000/year cap on out of pocket costs for Medicare patients and require drugmakers to pay rebates if their drug prices rise faster...Arizona News
Just this month a former head of sales for Phoenix-based Insys Therapeutics Alec Burlakoff, testified in a Boston federal court recounting directions he followed for years including: recruiting and bribing doctors to increase sales for Subsys. Burlakoff is the second to testify on the highly-addictive drug, following former CEO Michael...National News
Pharmaceutical companies Eli Lilly & Co. and AstraZeneca PLC are completely scrapping trials of an experimental drug they were co-developing for the treatment of Alzheimer's. It is an unsurprising announcement among various other disappointing efforts to close the gap to the finish line in the race against the debilitating...